Soft-tissue sarcoma is a relatively rare form of cancer.

The only reliable way to diagnose it is to perform biopsy, either intra-operatively or through the use of a fine needle to collect a sample so that the cytological study may confirm the diagnosis.

Therapeutic treatment depends on the stage of the disease; the main parameters affecting the choice of treatment method are the size of the tumour and the presence of metastases. The commonest site for soft-tissue sarcoma is the lungs. The basic and most usual treatment is surgical tumour resection, which may be accompanied by radiation therapy and/or chemotherapy.

Transarterial chemoembolisation/embolisation has significantly contributed towards reducing tumour size and stage and leading to remission of symptoms (pain, sense of heaviness). This state-of-the-art method often gives patients the opportunity to undergo surgical treatment, thus achieving longer life expectancy, avoiding amputation and improving their quality of life.

Dr Ioannis Dedes has been successfully performing – for longer than a decade – transarterial chemoembolisations/embolisations for soft-tissue sarcomas, achieving particularly high tumour shrinking rates.

Patients can then be operated or/and follow new chemotherapy or radiation therapy cycles with extremely encouraging final outcomes.

Ask Dr. I. Dede, what can you expect from a treatment. Examines your personal file and discusses it with you

pic 26-3

Soft-tissue sarcoma